he Trump administration is moving to reclassify marijuana under federal law, shifting it to a less restrictive category known as Schedule III. The proposal, announced on April 23, 2026, would mark a major change in how the drug is regulated in the United States.

If approved, the change would recognise that marijuana has accepted medical uses and a lower potential for abuse compared to substances in stricter categories. It would also ease some federal restrictions, including research limitations and tax burdens faced by cannabis-related businesses.

Officials say the move is part of a broader effort to align federal policy with evolving public opinion and state-level laws, where marijuana has already been legalised for medical or recreational use in many areas.

The proposal is still subject to a formal review process before it can take effect. However, it represents a significant shift in U.S. drug policy and could have wide-reaching impacts on the healthcare system, the cannabis industry, and law enforcement.

Join the Dadli News WhatsApp Group:  https://chat.whatsapp.com/L04JxtMbG39FLBbxYWlz9T